# US 2010/0293627 A1 · Method for cloning animals with targetted genetic alterations by transfer of long-term cultured male or female somatic cell nuclei, comprising artificially-induced genetic alterations, to enucleated recipient cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0293627 A1
- Document ID: US20100293627A1
- Status: Published application
- Kind: A1
- Application number: 12/689,114
- Filed: 2010-01-18
- Published: 2010-11-18
- Earliest claimed: 2000-01-04
- Assignees: University of Connecticut; The Governor of Kagoshima Prefecture
- Inventors: Xiangzhong YANG; Chikara KUBOTA
- Web page: https://patentgrep.com/patent/US20100293627A1

## CPC

- C12N 15/8771: {Bovine embryos}
- C12N 15/8777: {Rabbit embryos}
- A01K 2217/05: Animals comprising random inserted nucleic acids (transgenic)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

An improved method of nuclear transfer employing long-term cultured somatic cells as the donor cells and enucleated oocytes as the recipient cells to produce dividing cybrids. Such cybrids are useful for developing viable animals clones when nurtured in a suitable host environment.

## Claims

### Claim 1

A method of making a bovine cybrid by nuclear transfer comprising:
introducing a bovine donor cell or the nucleus of a bovine donor cell into an enucleated bovine oocyte to form a bovine cybrid,
wherein the donor cell is a somatic cell that is not from an embryo, a blastocyst, a fetus, or a sexually-related tissue (NENS somatic cell), and wherein the somatic cell has been cultured for more than five passages; and
harvesting the bovine cybrid.

### Claim 2 (depends on 1)

The method of claim 1, further comprising
activating the bovine cybrid.

### Claim 3 (depends on 1)

The method of claim 1, further comprising
culturing the bovine cybrid into a blastocyst.

### Claim 4 (depends on 3)

The method of claim 3, further comprising
transferring the blastocyst into the uterus of a bovine recipient.

### Claim 5 (depends on 1)

The method of claim 1, wherein the somatic cell has been cultured for at least 7 passages.

### Claim 6 (depends on 1)

The method of claim 1, wherein the somatic cell has been cultured for up to 15 passages.

### Claim 7 (depends on 1)

The method of claim 1, wherein the somatic cell is a fibroblast cell from an adult male bovine.

### Claim 8 (depends on 7)

The method of claim 7, wherein the fibroblast cell is from ear skin.

### Claim 9 (depends on 1)

The method of claim 1, wherein the somatic cell has been cultured in a serum-starved medium.

### Claim 10 (depends on 1)

The method of claim 1, further comprising:
before introducing the bovine donor cell or the nucleus into the enucleated bovine oocyte,
altering in a targeted manner the nuclear DNA of bovine NENS somatic cells to produce genetically-altered somatic cells;
culturing the somatic cells for five or more passages; and
selecting a genetically-altered somatic cell to be the bovine donor cell.

### Claim 11

A method of making a bovine cybrid by nuclear transfer comprising:
altering in a targeted manner the nuclear DNA of bovine somatic cells that are not from an embryo, a blastocyst, a fetus, or a sexually-related tissue (NENS somatic cells);
culturing the somatic cells for five or more passages;
selecting a genetically-altered somatic cell from the culture;
inserting the selected somatic cell or the nucleus of the selected somatic cell into an enucleated bovine oocyte to form a bovine cybrid;
optionally activating the bovine cybrid; and
harvesting the bovine cybrid.

### Claim 12 (depends on 11)

The method of claim 11, further comprising
culturing the bovine cybrid into a blastocyst.

### Claim 13 (depends on 11)

The method of claim 11, wherein the bovine somatic cells are ear skin fibroblast cells from an adult male bovine.

### Claim 14 (depends on 11)

The method of claim 11, wherein the targeted nuclear DNA alteration is a targeted gene inactivation.

### Claim 15

A method of making a mammalian cybrid by nuclear transfer, comprising
obtaining a diploid donor cell from a mammal, wherein the mammal is not a human or a mouse;
culturing the diploid donor cell for at least 14 and up to 30 cell doublings;
inserting a cultured diploid donor cell or the nucleus from a cultured diploid donor cell into an oocyte of the same mammalian species to form a cybrid;
optionally activating the cybrid; and
harvesting the cybrid.

### Claim 16 (depends on 15)

The method of claim 15, further comprising
culturing the cybrid into a blastocyst.

### Claim 17 (depends on 16)

The method of claim 16, further comprising
transferring the blastocyst into the uterus of a recipient of the same mammalian species.

### Claim 18 (depends on 15)

The method of claim 15, wherein the diploid donor cell is a fibroblast cell from an adult mammal.

### Claim 19 (depends on 15)

The method of claim 15, wherein obtaining the diploid donor cell comprises:
altering in a targeted manner the genome of diploid cells from the mammal;
culturing the diploid cells for at least 14 and up to 30 cell doublings; and
selecting a genetically-altered diploid cell to be the diploid donor cell.

### Claim 20

A method of making a mammalian cybrid by nuclear transfer, comprising:
obtaining diploid donor cells from a mammal which is not a human or a mouse altering in a targeted manner the genome of the diploid donor cells;
culturing the diploid donor cells for at least 14 and up to 30 cell doublings;
selecting a genetically-altered diploid donor cell from the cultured cells;
inserting the selected cell or the nucleus of the selected cell into an oocyte from the same species of mammal to form a cybrid;
optionally activating the cybrid; and
harvesting the cybrid.

### Claim 21 (depends on 20)

The method of claim 20, wherein the targeted genome alteration is a targeted gene inactivation.
